Objective: The aim of this study was to assess the correlation between atypical squamous cells (ASC) and inflammatory infiltrate and vaginal microbiota using cervical liquid-based cytological (SurePath®) and high-risk human papillomavirus (HR-HPV) tests. Study Design: A cross-sectional study was conducted using a 6-year database from a laboratory in Fortaleza (Brazil). Files from 1,346 ASC cases were divided into subgroups and results concerning inflammation and vaginal microorganisms diagnosed by cytology were compared with HR-HPV test results. Results: An absence of specific microorganisms (ASM) was the most frequent finding (ASC of undetermined significance, ASC-US = 74%; ASC - cannot exclude high-grade squamous intraepithelial lesion, ASC-H = 68%), followed by bacterial vaginosis (ASC-US = 20%; ASC- H = 25%) and Candida spp. (ASC-US = 6%; ASC-H = 5%). Leukocyte infiltrate was present in 71% of ASC-US and 85% of ASC-H (p = 0.0040), and in these specific cases HR-HPV tests were positive for 65 and 64%, respectively. A positive HR-HPV test was relatively more frequent when a specific microorganism was present, and Candida spp. was associated with HR-HPV-positive results (p = 0.0156), while an ASM was associated with negative HR-HPV results (p = 0.0370). Conclusion: ASC-US is associated with an absence of inflammation or vaginosis, while ASC-H smears are associated with Trichomonas vaginalis and inflammatory infiltrate. A positive HR-HPV is associated with Candida spp. in ASC cytology.

1.
Nayar R, Wilbur DC: The Pap test and Bethesda 2014. Cancer Cytopathol 2015;123:271-281.
2.
Jahic M, Jahic E: Diagnostic approach to patients with atypical squamous cells of undetermined significance cytologic findings on Cervix. Med Arch 2016;70:296-298.
3.
López-Alegría F, Poblete O, De Lorenzi D, Oyanedel J: Clinical management of the first ASCUS report in Chile: prospective single-cohort study. Sao Paulo Med J 2015;133:480-487.
4.
Schiffman M, Vaughan L, Raine-Bennett T, Castle P, Katki H, Gage J, Fetterman B, Befano B, Wentzensen N: A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results. Gynecol Oncol 2015;138:573-578.
5.
Won K, Lee J, Cho H, Suh D, No J, Kim Y: Impact of age on the false negative rate of human papillomavirus DNA test in patients with atypical squamous cells of undetermined significance. Obstet Gynecol Sci 2015;58:117-123.
6.
Watson M, Benard V, Lin L, Rockwell T, Royalty J: Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance. Cancer Causes Control 2015;26:759-764.
7.
Eleutério J Jr, Cavalcante D: Mobiluncus sp morphotype counts and leukocyte concentrations in vaginal smears of patients with BV. Rev Bras Ginecol Obstet 2004;26:221-225.
8.
Linhares IM, Giraldo PC, Baracat EC: Novos conhecimentos sobre a flora bacteriana vaginal. Rev Assoc Med Bras 2010;56:370-374.
9.
Borras EV, Rodríguez CJ: Síndrome de flujo vaginal. Rev Cubana Obstet Ginecol 2010;36:594-602.
10.
Bukhari M, Majeed M, Qamar S, Niazi S, Syed S, Yusuf A: Clinicopathological study of Papanicolaou (Pap) smears for diagnosing of cervical infections. Diagn Cytopathol 2010;40:35-41.
11.
Donders GGG, Depuydt CE, Bogers J-P, Vereecken AJ: Association of Trichomonas vaginalis and cytological abnormalities of the cervix in low risk women. PLoS One 2013;8:e86266.
12.
Gupta S, Sodhani P, Chachra K, Singh V, Sehgal A: Outcome of “atypical squamous cells” in a cervical cytology screening program: implications for follow up in resource limited settings. Diagn Cytopathol 2007;35:677-680.
13.
Silva M, Almeida R, Bastos E, Nobre F: Determinantes da detecção de atipias celulares no programa de rastreamento do câncer do colo do útero no Rio de Janeiro, Brasil. Rev Panam Salud Publica 2013;34:107-113.
14.
Nasser H, Hayek S, Balasubramaniam M, Kuntzman TJ: Infectious organisms on Papanicolaou smears should not influence the diagnosis of atypical squamous cells of undetermined significance. Acta Cytol 2011;55:251-254.
15.
Ghosh I, Mandal R, Kundu P, Biswas J: Association of genital infections other than human papillomavirus with pre-invasive and invasive cervical neoplasia. J Clin Diagn Res 2016;10:XE01-XE06.
16.
Eleutério J Jr, Passos M, Giraldo PC, Linhares IM, Carvalho NS: Estudo em Citologia em Meio Líquido (SurePath) da Associação de Candida sp. em Mulheres com Diagnóstico de Vaginose Bacteriana. J Bras Doenças Sex Transm 2012;24:122-123.
17.
Silva C, Almeida EC, Côbo EC, Zeferino VF, Murta EF, Etchebehere RM: A retrospective study on cervical intraepithelial lesions of low-grade and undetermined significance: evolution, associated factors and cytohistological correlation. Sao Paulo Med J 2014;132:92-96.
18.
Bhatla N, Puri K, Joseph E, Kriplani A, Iyer VK, Sreenivas V: Association of Chlamydia trachomatis infection with human papillomavirus (HPV) and cervical intraepithelial neoplasia - a pilot study. Indian J Med Res 2013;137:533-539.
19.
Zhang D, Li T, Chen L, Zhang X, Zhao G, Liu Z: Epidemiological investigation of the relationship between common lower genital tract infections and high-risk human papillomavirus infections among women in Beijing, China. PLoS One 2017;12:e0178033.
20.
Tafurt-Cardona Y, Acosta-Astaiza C, Sierra-Torres C: Prevalencia de citología anormal e inflamación y su asociación con factores de riesgo para neoplasias del cuello uterino en el Cauca, Colombia. Rev Salud Pública 2012;14:53-66.
21.
Bazán-Ruiz S, Valladares-Garrido D, Benites-Cóndor Y, Bendezú-Quispe G, Ruiz-Leud M, Mejia C: Severidad de la inflamación en los reportes de Papanicolaou según agente etiológico encontrado en un hospital público del norte de Perú. Rev Chil Obstet Ginecol 2016;81:32-37.
22.
Barcelos A, Michelin M, Adad S, Murta EF: Atypical squamous cells of undetermined significance: Bethesda classification and association with human papillomavirus. Infect Dis Obstet Gynecol 2011;2011:904674.
23.
Paba P, Criscuolo AA, Grazia Giancipoli R, Santi F, Ascone C, Sesti F, Piccione E, Perno CF, Favalli C, Ciotti M: Microbiological infections in women with cervical cytological reports of atypical squamous cells of undetermined significance. J Low Genit Tract Dis 2015;19:203-206.
24.
Duarte H, Romero J, Schmalbach J: Asociación de la citología cervico-vaginal inflamatoria con la lesión intraepitelial cervical en pacientes de una clínica de salud sexual y reproductiva en Bogotá, Colombia 1999-2003. Rev Salud Pública 2004;6:253-269.
25.
Kero K, Rautava J, Syrjänen K, Grenman S, Syrjänen S: Association of asymptomatic bacterial vaginosis with persistence of female genital human papillomavirus infection. Eur J Clin Microbiol Infect Dis DOI: 10.1007/s10096-017-3048-y.
26.
Longatto-Filho A, Erzen M, Branca M, Roteli-Martins C, Naud P, Derchain SFM, Hammes L, Sarian LO, Bragança JF, Matos J, Gontijo R, Lima T, Maeda MYS, Tatti S, Syrjänen S, Dores G, Lörincz A, Syrjänen K: Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening Study. Int J Gynecol Cancer 2006;16:955-962.
27.
Rebouças K, Eleutério J Jr, Eleutério R, Augusto K, Leopoldo K: Influence of human papillomavirus Infection on the vaginal microbiome of women with immunocompetency. J Bras Doenças Sex Transm 2014;26:5-9.
28.
Levi J, Longatto-Filho A, Eluf-Neto J, Rodrigues C, Oliveira C, Carloni A, Lorenzi A, Tacla M, Fregnani J, Ab'Saber A, Scapulatempo C, Villa L: Evaluation of HPV molecular tests in primary screening for cervical cancer in Brazil. Open J Obstet Gynecol 2014;4:470-478.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.